Long-term follow-up of larynx leukoplakia under treatment with retinyl palmitate

Head and Neck

Volumn 18, Issue 6, 1996, Pages 560-565

  Issing, Wolfgang J ^a   Struck, Rainer ^a   Naumann, Andreas ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOL; RETINOL PALMITATE;

ADULT; AGED; ARTICLE; CANCER PREVENTION; CHEILITIS; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRY SKIN; FEMALE; FOLLOW UP; HUMAN; LARYNGOSCOPY; LARYNX CANCER; LEUKOPLAKIA; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029826103     PISSN: 01486403     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0347(199611/12)18:6<560::aid-hed11>3.0.co;2-c     Document Type: Article

References (30)

1. Boring CC, Squires TS, Tong T. Cancer statistics, 1991. CA 1991;41:19-36.
2. Lippman SM, Hong WK. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys 1989;17:691-694.
3. Lippman SM, Hong WK. 13-cis-retinoic acid and cancer chemoprevention. J Natl Cancer Inst Monogr 1992; 13:111-115.
4. Strong MS, Incze J, Vaughan CW. Field cancerization in the aerodigestive tract: its etiology, manifestation, and significance. J Otolaryngol 1984;13:1-6.
5. Kelloff GJ, Boone CW, Steele VK, et al. Development of chemopreventive agents for lung and upper aerodigestive tract cancers. J Cell Biochem 1993;17F(suppl):2-17.
6. Hong WK, Lippman SM, Itri LW, et al. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N Engl J Med 1990;323:795-801.
7. American Cancer Society: Cancer, Facts and Figures 1993. Atlanta, Georgia, ACS, 1993.
8. Maran AGD, Wilson JA, Gaze MN. The nature of the head and neck cancer. Eur Arch Otorhinolaryngol 1993;250:127-132.
9. Acheson ED, Cowdell RH, Hadfield E, et al. Nasal cancer in wood workers in the furniture industry. Br Med J 1968;2:587-590.
10. de Vries N, van Zandwijk N, Pastorino U. The curoscan study. Br J Cancer 1991;64:985-989.
11. Duchon J, Czinger J, Pupp L. Stimmbandpachydermien und das Rauchen. Z Laryngol Rhinol 1972;51:253-255.
12. Lippman SM, Batsakis JG, Toth BB, et al. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med 1993;328:15-20.
13. Silverman S Jr, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation: a follow-up study of 257 patients. Cancer 1984;53:563-568.
14. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1953;6:963-968.
15. Lippman SM, Benner SE, Hong WK. Chemoprevention strategies in lung carcinogenesis. Chest 1993;103: 15S-19S.
16. Chiesa F, Tradati N, Marazza M, et al. Prevention of local relapses and new localisations of oral leukoplakias with the synthetic retinoid fenretinide (4-HPR): preliminary results. Oral Oncol, Eur J Cancer 1992;2:97-102.
17. Frame JW, Dasgupta AR, Dalton GA. Use of the carbon dioxide laser in the management of premalignant lesions of the oral mucosa. J Laryngol Otol 1984;98:1251-1260.
18. Chiesa F, Sala L, Costa L, et al. Excision of oral leukoplakia by carbon dioxide laser on an out-patient basis: a useful procedure for prevention and early detection of oral carcinoma. Tumori 1986;2:307-312.
19. Chu FWK, Silverman S Jr, Dedo HH. Carbon dioxide laser treatment of oral leukoplakia. Laryngoscope 1988;98:125-130.
20. Smith MA, Parkinson DR, Cheson BD, et al. Retinoids in cancer therapy. J Clin Oncol 1992;10:839-864.
21. Lotan R, Xu X-C, Lippman SM, et al. Suppression of retinoic acid receptor β in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med 1995;332:1405-1410.
22. Sporn B. Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res 1976;36:2699-2702.
23. Pastorino U, infante M, Maioli M, et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 1993;11:1216-1222.
24. Ajani JA, Welch SR, Raber MN, et al. Comprehensive criteria for assessing therapy-induced toxicity. Cancer Invest 1990;8:147-159.
25. Meyskens FL Jr, Goodman GE, Alberts DS. 13-cis-retinoic acid: pharmacology, toxicology, and clinical applications for the prevention and treatment of human cancer. Crit Rev Oncol Hematol 1985;3:75-101.
26. Hong WK, Endicott J, Itri LM, et al. 13-czs-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986;315:1501-1505.
27. Stich HF, Rosin MP, Hornby AP, et al. Remission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with beta-carotene and with beta-carotene plus vitamin A. Int J Cancer 1988;42:195-199.
28. Stich HF, Hornby AP, Mathew B, et al. Response of oral leukoplakia to the administration of vitamin A. Cancer Lett 1988;40:93-101.
29. Blomhoff R, Green MH, Berg T, et al. Transport and storage of Vitamin A. Science 1990;250:399-404.
30. Benner SE, Hong WK, Lippman SM, et al. Intermediate biomarkers in upper aerodigestive tract and lung chemoprevention trials. J Cell Biochem 1992;16G(suppl):33-38.